• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆置换疗法治疗甲亢合并白细胞减少症

Plasmapheresis in the therapy of hyperthyroidism associated with leukopenia.

作者信息

De Rosa G, Testa A, Menichella G, Cecchini L, Cavallaro A, Mantovani M, Mango G

机构信息

Department of Endocrinology, Università, Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Haematologica. 1991 Mar;76 Suppl 1:72-4.

PMID:1713877
Abstract

Surgery, the treatment of choice for hyperthyroidism due to nodular goiter, requires an euthyroid state, which is generally achieved with thionamides. Leukopenia is the most serious toxic effect of thionamides, and it causes controindication. We report a 50-year old woman with severe hyperthyroidism and leukopenia, in whom an euthyroid state before thyroidectomy was obtained with the use of therapeutic plasmapheresis. This procedure was carried out immediately before surgery using an intermittent flow separator; three sessions removed a total of 6,300 cc of plasma. Plasmapheresis caused a rapid reduction of both total and free thyroid hormone levels. Thyroidectomy was performed without any complications. Plasmapheresis can be considered a valid and safe method to prepare hyperthyroid patients for thyroidectomy when other therapies are ineffective or counterindicated.

摘要

手术是结节性甲状腺肿所致甲状腺功能亢进的首选治疗方法,需要甲状腺功能正常状态,这通常通过硫代酰胺类药物来实现。白细胞减少是硫代酰胺类药物最严重的毒性作用,可导致禁忌。我们报告了一名50岁患有严重甲状腺功能亢进和白细胞减少的女性,通过治疗性血浆置换在甲状腺切除术前达到了甲状腺功能正常状态。该操作在手术前立即使用间歇流分离器进行;三次治疗共去除6300毫升血浆。血浆置换导致总甲状腺激素和游离甲状腺激素水平迅速降低。甲状腺切除术顺利完成,无任何并发症。当其他治疗无效或禁忌时,血浆置换可被视为一种为甲状腺功能亢进患者进行甲状腺切除术做准备的有效且安全的方法。

相似文献

1
Plasmapheresis in the therapy of hyperthyroidism associated with leukopenia.血浆置换疗法治疗甲亢合并白细胞减少症
Haematologica. 1991 Mar;76 Suppl 1:72-4.
2
[The management of thyrotoxicosis: a schematic approach].[甲状腺毒症的管理:一种示意性方法]
Minerva Endocrinol. 2002 Jun;27(2):119-26.
3
Effective Preoperative Plasmapheresis Treatment of Severe Hyperthyroidism in a Patient with Giant Toxic Nodular Goiter and Methimazole-Induced Agranulocytosis.大剂量甲巯咪唑诱导粒细胞缺乏症的巨毒性结节性甲状腺肿患者重度甲状腺功能亢进的有效术前血浆置换治疗。
Medicina (Kaunas). 2020 Jun 12;56(6):290. doi: 10.3390/medicina56060290.
4
[Subtotal thyroid resection in severe, iodine-induced hyperthyroidism].[严重碘致甲状腺功能亢进症的甲状腺次全切除术]
Chirurg. 1985 Sep;56(9):594-8.
5
Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: A case report.血浆置换治疗粒细胞缺乏症相关的甲状腺功能亢进症:一例报告
J Clin Apher. 2004;19(3):148-50. doi: 10.1002/jca.20014.
6
[Postoperative course and tactics of aftercare in hyperthyroidism].[甲状腺功能亢进症的术后病程及术后护理策略]
Chirurg. 1984 Mar;55(3):171-3.
7
Preoperative therapeutic plasma exchange in patients with thyrotoxicosis.甲状腺毒症患者的术前治疗性血浆置换
J Clin Apher. 2009;24(3):111-4. doi: 10.1002/jca.20200.
8
[Surgical treatment of nodular hyperthyroidism].[结节性甲状腺功能亢进症的外科治疗]
Ann Ital Chir. 1989 Sep-Oct;60(5):373-6.
9
Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti-thyroid drug-associated angioedema.术前血浆置换治疗甲状腺功能亢进症伴抗甲状腺药物相关性血管性水肿孕妇的疗效。
Gynecol Endocrinol. 2013 May;29(5):508-10. doi: 10.3109/09513590.2012.754871. Epub 2013 Feb 6.
10
Diagnosis and management of large toxic multinodular goiters.巨大毒性多结节性甲状腺肿的诊断与管理
J Nucl Med. 1985 Aug;26(8):888-92.

引用本文的文献

1
Preoperative Therapeutic Plasma Exchange and Surgical Treatment in Thyrotoxicosis Patients: A Single-Centre Retrospective Cohort Study.甲状腺毒症患者的术前治疗性血浆置换与手术治疗:一项单中心回顾性队列研究
Acta Endocrinol (Buchar). 2021 Jul-Sep;17(3):346-350. doi: 10.4183/aeb.2021.346.
2
Effective Preoperative Plasmapheresis Treatment of Severe Hyperthyroidism in a Patient with Giant Toxic Nodular Goiter and Methimazole-Induced Agranulocytosis.大剂量甲巯咪唑诱导粒细胞缺乏症的巨毒性结节性甲状腺肿患者重度甲状腺功能亢进的有效术前血浆置换治疗。
Medicina (Kaunas). 2020 Jun 12;56(6):290. doi: 10.3390/medicina56060290.
3
Therapeutic plasmapheresis in thyrotoxic patients.
甲状腺毒症患者的治疗性血浆置换。
Endocrine. 2018 Oct;62(1):144-148. doi: 10.1007/s12020-018-1661-x. Epub 2018 Jul 2.
4
Severe Hyperthyroidism Complicated by Agranulocytosis Treated with Therapeutic Plasma Exchange: Case Report and Review of the Literature.治疗性血浆置换治疗重度甲状腺功能亢进症合并粒细胞缺乏症:病例报告及文献复习
Case Rep Endocrinol. 2018 Jan 10;2018:4135940. doi: 10.1155/2018/4135940. eCollection 2018.